Candel Therapeutics (CADL) Change in Account Payables (2020 - 2025)
Candel Therapeutics' (CADL) quarterly Change in Account Payables came in at $33000.0 in Q4 2025, up 158.93% year-on-year from $12744.8 in Q4 2024, and up 104.44% quarter-over-quarter from -$744000.0 in Q3 2025.
Candel Therapeutics (CADL) Change in Account Payables (2020 - 2025) Analysis & Trends
Candel Therapeutics has disclosed Change in Account Payables across 6 years of filings, most recently posting $33000.0 for Q4 2025.
- Change in Account Payables for Q4 2025 came in at $33000.0, up 158.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $802000.0 (up 533.51% YoY), and the FY2025 annual result was $802000.0, up 533.51% from the prior year.
- Change in Account Payables came in at $33000.0 for Q4 2025 at Candel Therapeutics, up from -$744000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2025 to a low of -$744000.0 in Q3 2025.
- The 5-year median for Change in Account Payables is -$3000.0 (2024), against an average of $5900.0.
- Across the five-year window, Change in Account Payables plunged 434.68% in 2022 and soared 2679.49% in 2025, its largest moves.
- Candel Therapeutics' Change in Account Payables stood at $665000.0 in 2021, then slumped by 181.8% to -$544000.0 in 2022, then surged by 131.62% to $172000.0 in 2023, then plunged by 132.56% to -$56000.0 in 2024, then soared by 158.93% to $33000.0 in 2025.
- The last three Change in Account Payables figures came in at $33000.0 (Q4 2025), -$744000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | 33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | -744,000.00 |
| Sep 30, 2025 | -744,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 507,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Sep 30, 2023 | -214,000.00 |
| Sep 30, 2023 | -214,000.00 |